Alterations of Oligodendrocyte and Myelin Energy Metabolism in Multiple Sclerosis
International Journal of Molecular Sciences · 18.08.2023 · 24 (16) · 12912
DOI: 10.3390/ijms241612912 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.08.2023. Verfasst von Eneritz López-Muguruza und 1 weiteren Autor:innen. Beteiligte Einrichtung: Achucarro Basque Center for Neuroscience, 48940 Leioa, Spain. Hauptthemen laut MEDLINE: Myelin Sheath, Multiple Sclerosis. Die Arbeit wurde bisher 128-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biomedical Research Networking Center on Neurodegenerative Diseases, Spanish Ministry of Science and Innovation, Basque Govern.
Abstract (Originalsprache)
Multiple sclerosis (MS) is a complex autoimmune disease of the central nervous system (CNS), characterized by demyelination and neurodegeneration. Oligodendrocytes play a vital role in maintaining the integrity of myelin, the protective sheath around nerve fibres essential for efficient signal transmission. However, in MS, oligodendrocytes become dysfunctional, leading to myelin damage and axonal degeneration. Emerging evidence suggests that metabolic changes, including mitochondrial dysfunction and alterations in glucose and lipid metabolism, contribute significantly to the pathogenesis of MS. Mitochondrial dysfunction is observed in both immune cells and oligodendrocytes within the CNS of MS patients. Impaired mitochondrial function leads to energy deficits, affecting crucial processes such as impulse transmission and axonal transport, ultimately contributing to neurodegeneration. Moreover, mitochondrial dysfunction is linked to the generation of reactive oxygen species (ROS), exacerbating myelin damage and inflammation. Altered glucose metabolism affects the energy supply required for oligodendrocyte function and myelin synthesis. Dysregulated lipid metabolism results in changes to the composition of myelin, affecting its stability and integrity. Importantly, low levels of polyunsaturated fatty acids in MS are associated with upregulated lipid metabolism and enhanced glucose catabolism. Understanding the intricate relationship between these mechanisms is crucial for developing targeted therapies to preserve myelin and promote neurological recovery in individuals with MS. Addressing these metabolic aspects may offer new insights into potential therapeutic strategies to halt disease progression and improve the quality of life for MS patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Achucarro Basque Center for Neuroscience, 48940 Leioa, Spain.
- Department of Neurosciences, University of the Basque Country UPV/EHU, 48940 Leioa, Spain.
- Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), 28031 Madrid, Spain.
ORCID-Profile: Carlos Matute
Förderung
- Biomedical Research Networking Center on Neurodegenerative Diseases
- Spanish Ministry of Science and Innovation
- Basque Govern
- Centro de Investigación Biomédica en Red and Enfermedades Neurodegenerativas (CIBERNED)
Zitieren
APA
López-Muguruza, E., & Matute, C. (2023). Alterations of Oligodendrocyte and Myelin Energy Metabolism in Multiple Sclerosis. International Journal of Molecular Sciences, 24(16), 12912. https://doi.org/10.3390/ijms241612912
Vancouver
López-Muguruza E, Matute C. Alterations of Oligodendrocyte and Myelin Energy Metabolism in Multiple Sclerosis. International Journal of Molecular Sciences. 2023;24(16):12912. doi:10.3390/ijms241612912
BibTeX
@article{LpezMuguruza2023,
author = {López-Muguruza, Eneritz and Matute, Carlos},
title = {Alterations of Oligodendrocyte and Myelin Energy Metabolism in Multiple Sclerosis},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {16},
pages = {12912},
doi = {10.3390/ijms241612912}
}
EUVIMED